Clinical Trial Update: Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol [Phase 4]

View source ↗

Summary

This entry provides an update on a Phase 4 trial evaluating thymoglobulin in a calcineurin inhibitor and steroid minimization protocol; the current trial status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Organ Transplant Rejection

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Diabetes, Graft Rejection | Phase 4 | Status: UNKNOWN